Distinct Oligoclonal T Cells Are Associated With Graft Versus Host Disease After Stem-Cell Transplantation
Authors:
- Maciej KmieciakMKMaciej Kmieciak
- Roy T. SaboRSRoy T. Sabo
- Catherine H. RobertsCRCatherine H. Roberts
- Michael O. IdowuMIMichael O. Idowu
- Katherine MalloryKMKatherine Mallory
- Harold M. ChungHCHarold M. Chung
- John M. McCartyJMJohn M. McCarty
- Christian A. BorrelliCBChristian A. Borrelli
- Michelle M. DetwilerMDMichelle M. Detwiler
- A. Latif KazimAKA. Latif Kazim
- Amir A. ToorATAmir A. Toor
- 15 May 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 93 (9) , 949-957
Abstract
In patients with hematologic malignancies who receive stem-cell transplantation, donors' T cells can recognize minor histocompatibility antigens on recipient cells and generate an objective response against the tumor. However, a major side effect of such therapy is graft-versus-host disease (GVHD). The purpose of this study was to characterize distinct T-cell clones that were frequently and exclusively involved in GVHD or graft-versus-tumor (GVT) effects. We hypothesized that distinct GVHD-associated T-cell clones can be identified during the disease progression. To test this, we conducted comparative analysis of T-cell receptor (TCR) Vβs in donor-recipient pairs of patients with GVHD versus those with GVHD-free and relapse-free survival using quantitative reverse-transcriptase polymerase chain reaction and spectratyping analyses. We identified three sets of T-cell clones that were either frequently involved in GVHD (TCR Vβ4, 11, and 23) or GVT effect (TCR Vβ9, 16, and 20), or were increased at the time of GVHD and GVT effects in a patient-specific manner (TCR Vβ2, 3, 7, 12, 15, and 17). Spectratyping analysis showed restricted clonality of the identified TCR Vβs. Polymerase chain reaction analysis also confirmed the presence of GVHD-associated T-cell clones at the site of the disease. These data suggest that GVHD- and GVT-associated clones can be distinguished by molecular analysis of TCR Vβ to develop targeted therapy for GVHD.Keywords
This publication has 26 references indexed in Scilit:
- One-Antigen Mismatched Related versus HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Adults with Acute Leukemia: Center for International Blood and Marrow Transplant Research Results in the Era of Molecular HLA TypingTransplantation and Cellular Therapy, 2011
- Effects of Mismatching for Minor Histocompatibility Antigens on Clinical Outcomes in HLA-Matched, Unrelated Hematopoietic Stem Cell TransplantsTransplantation and Cellular Therapy, 2009
- Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCTBone Marrow Transplantation, 2008
- Targets of Tumor Immunity After Allogeneic Hematopoietic Stem Cell TransplantationClinical Cancer Research, 2008
- Graft-versus-host diseaseNature Reviews Immunology, 2007
- Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacyLeukemia, 2007
- Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative ConditioningJournal of Clinical Oncology, 2005
- Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.Journal of Clinical Oncology, 1997
- Mismatches of Minor Histocompatibility Antigens between HLA-Identical Donors and Recipients and the Development of Graft-Versus-Host Disease after Bone Marrow TransplantationNew England Journal of Medicine, 1996
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990